Point72 Asset Management’s Vir Biotechnology VIR Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | – | Sell |
-848,454
| Closed | -$6.23M | – | 1838 |
|
2024
Q4 | $6.23M | Buy |
848,454
+843,239
| +16,169% | +$6.19M | 0.01% | 639 |
|
2024
Q3 | $39.1K | Sell |
5,215
-12,385
| -70% | -$92.8K | ﹤0.01% | 1168 |
|
2024
Q2 | $157K | Sell |
17,600
-14,900
| -46% | -$133K | ﹤0.01% | 1032 |
|
2024
Q1 | $329K | Buy |
32,500
+24,500
| +306% | +$248K | ﹤0.01% | 1106 |
|
2023
Q4 | $80.5K | Buy |
8,000
+4,900
| +158% | +$49.3K | ﹤0.01% | 1238 |
|
2023
Q3 | $29K | Sell |
3,100
-508,500
| -99% | -$4.76M | ﹤0.01% | 1552 |
|
2023
Q2 | $12.5M | Sell |
511,600
-1,171,500
| -70% | -$28.7M | 0.04% | 461 |
|
2023
Q1 | $39.2M | Buy |
+1,683,100
| New | +$39.2M | 0.12% | 200 |
|
2022
Q4 | – | Sell |
-54,496
| Closed | -$1.05M | – | 1423 |
|
2022
Q3 | $1.05M | Buy |
+54,496
| New | +$1.05M | ﹤0.01% | 837 |
|
2022
Q1 | – | Sell |
-2,055,100
| Closed | -$86M | – | 1304 |
|
2021
Q4 | $86M | Buy |
2,055,100
+2,033,400
| +9,371% | +$85.1M | 0.34% | 56 |
|
2021
Q3 | $944K | Buy |
+21,700
| New | +$944K | ﹤0.01% | 809 |
|